首页> 美国卫生研究院文献>Journal of Clinical Medicine >Adherence to Glaucoma Medications Over 12 Months in Two US Community Pharmacy Chains
【2h】

Adherence to Glaucoma Medications Over 12 Months in Two US Community Pharmacy Chains

机译:在两个美国社区药房连锁店中坚持青光眼药物治疗超过12个月

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

This study determined the degree of adherence to medications for glaucoma among patients refilling prescriptions in community pharmacies. Methods: Data abstracted from the dispensing records for 3615 adult patients (18 years or older, predominantly over 45) receiving glaucoma medications from two retail pharmacy chains (64 stores in total) were analyzed. From a 24-month historic data capture period, the 12-month levels of adherence were determined using standard metrics, the proportion of days covered (PDC) and the medication possession ratio (MPR). The overall 12-month mean PDC was only 57%, and the mean MPR was 71%. Using a criterion by which 80% coverage was considered satisfactory adherence, only 30% had satisfactory overall 12-month PDC coverage, and only 37% had satisfactory overall 12-month MPR coverage. Refill adherence increased with age and was highest in the 65-and-older age group (p < 0.001). Differential adherence was found across medication classes, with the highest satisfactory coverage seen for those taking alpha2-adrenergic agonists (PDC = 36.0%; MPR = 47.6%) down to those taking direct cholinergic agonists (PDC = 25.0%; MPR = 31.2%) and combination products (PDC = 22.7%; MPR = 31.0%). Adherence to glaucoma medications in the community setting, as measured by pharmacy refill data, is very poor and represents a critical target for intervention. Community pharmacists are well positioned to monitor and reinforce adherence in this population.
机译:这项研究确定了社区药房中补充处方的患者对青光眼药物的依从程度。方法:分析了从两个零售药房连锁店(总共64家商店)接受青光眼药物治疗的3615名成年患者(18岁或以上,主要是45岁以上)的配药记录中提取的数据。从24个月的历史数据捕获期开始,使用标准指标,覆盖天数(PDC)和药物拥有率(MPR)确定12个月的依从性水平。整个12个月的平均PDC仅为57%,平均MPR为71%。使用80%的覆盖率被认为是令人满意的遵守标准,只有30%的12个月的PDC总体覆盖率令人满意,只有37%的12个月的MPR总体覆盖率令人满意。笔芯依从性随年龄增加而增加,在65岁及以上年龄组最高(p <0.001)。跨药物类别发现差异依从性,接受α2-肾上腺素能激动剂(PDC = 36.0%; MPR = 47.6%)的患者和直接接受胆碱能激动剂(PDC = 25.0%; MPR = 31.2%)的患者满意率最高。和组合产品(PDC = 22.7%; MPR = 31.0%)。通过药房补充数据衡量,在社区环境中对青光眼药物的依从性非常差,是干预的关键目标。社区药剂师处于良好的位置,可以监测和加强这一人群的依从性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号